Cargando...
Intranasal oxytocin dampens cue-elicited cigarette craving in daily smokers: A pilot study
Despite moderate success with pharmacological and behavioral treatments, smoking relapse rates remain high, and many smokers report that smoking cues lead to relapse. Therefore, treatments that target cue reactivity are needed. One candidate for reducing craving is the neuropeptide oxytocin (OT). He...
Gardado en:
| Publicado en: | Behav Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5089916/ https://ncbi.nlm.nih.gov/pubmed/27661192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FBP.0000000000000260 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|